대한약품 Stock: price and insider trades · South Korea
1 insider bought €18k of shares over the last 90 days, the latest by 이윤우, filed 30 Sept 2026.
대한약품: what insiders have been doing
This page follows insider dealings at 대한약품 as filed with DART (FSS), a company from the Health Care sector. 3 insiders have disclosed 22 filings since 6 November 2025.
Open-market activity splits into 19 purchases totalling €16k and 2 sales; 1 insider sit on the buying side and 1 insider on the selling side. The totals do not cover 20 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Those buying include 1 chief executive. Biggest ticket of the year: €16k, bought by 이윤우 and made public on 28 May 2026.
The latest purchase dates back some time: it was published 41 days ago, on 30 September 2026.
With 22 filings in twelve months, the company is more active than the median of 7 filings across the 2,658 companies we follow on the same exchange. Since 2021, the database holds 69 purchases and 2 sales by insiders of the company.
In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -5.6%Entry ₩26,700 · Close 04 Nov 2026 ₩25,200
- -8.1%Entry ₩27,950 · Close at T+365 ₩25,700
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- Other0DART
- 834 sharesShareKRXDART:20260930000599Canonical exit: 29 Dec 2026 (T+90)
- 200 sharesShareKRXDART:20260831001265Canonical exit: 29 Nov 2026 (T+90)
- 836 sharesShareKRXDART:20260807000499Canonical exit: 5 Nov 2026 (T+90)
- Other0DART
- Other0DART
- 1,122 sharesShareKRXDART:20260716000628Canonical exit: 14 Oct 2026 (T+90)
- 2,019 sharesShareKRXDART:20260709000481Canonical exit: 7 Oct 2026 (T+90)
- 4,499 sharesShareKRXDART:20260630000770Canonical exit: 28 Sept 2026 (T+90)
- 1,192 sharesShareKRXDART:20260622000247Canonical exit: 20 Sept 2026 (T+90)
- 2,712 sharesShareKRXDART:20260612000477Canonical exit: 10 Sept 2026 (T+90)
- 4,387 sharesShareKRXDART:20260605000436Canonical exit: 3 Sept 2026 (T+90)
- 60,167 sharesKRXDART:20260528000765Canonical exit: 26 Aug 2026 (T+90)
- 1,000 shares@ ₩27,230.20100.0% of flowShareKRXDART:20260528000744Canonical exit: 24 Aug 2026 (T+90)
- 800 sharesShareKRXDART:20260522000410Canonical exit: 20 Aug 2026 (T+90)
- ●Executives0DART
- 600 sharesShareKRXDART:20260129000731Canonical exit: 29 Apr 2026 (T+90)
- 6,600 sharesShareKRXDART:20260122000463Canonical exit: 22 Apr 2026 (T+90)
- 4,180 sharesShareKRXDART:20260115000347Canonical exit: 15 Apr 2026 (T+90)
- 2,800 sharesShareKRXDART:20260108000507Canonical exit: 8 Apr 2026 (T+90)
- 5,660 sharesShareKRXDART:20251230000794
25 of 154 declarations
About 대한약품
대한약품 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the manufacturing of pharmaceutical products and medications.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
